Bevacizumab in heavily pre-treated ovarien cancer patients and the predictive value of serum VEGF

Maja Smerdel, Karina Dahl Steffensen, Marianne Waldstrøm, Ivan Brandslund, Anders Jakobsen

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication date2009
Publication statusPublished - 2009
EventECCO 15-ESMO34 (ECCO - the European Cancer Organisation - ESMO - the European Society for Medical Oncology) - Berlin, Germany
Duration: 20. Sep 200924. Sep 2009

Conference

ConferenceECCO 15-ESMO34 (ECCO - the European Cancer Organisation - ESMO - the European Society for Medical Oncology)
Country/TerritoryGermany
CityBerlin
Period20/09/200924/09/2009

Bibliographical note

Citation: European Journal of Cancer Supplements, Volume 7, Issue 2, September 2009, Page 451

Oral presentation

Cite this